Display options
Share it on

BMC Public Health. 2021 Dec 13;21(1):2276. doi: 10.1186/s12889-021-12371-7.

Wrist circumference as a novel predictor of transition from metabolically healthy to unhealthy phenotype in overweight/obese adults: a gender-stratified 15.5-year follow-up.

BMC public health

Pouria Mousapour, Maryam Barzin, Majid Valizadeh, Maryam Mahdavi, Farzad Hadaegh, Fereidoun Azizi, Farhad Hosseinpanah

Affiliations

  1. Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  2. Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  3. Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  4. Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. [email protected].

PMID: 34903195 DOI: 10.1186/s12889-021-12371-7

Abstract

BACKGROUND: Individuals with transition from metabolically healthy overweight/obese (MHO) to metabolically unhealthy overweight/obese (MUO) phenotype are significantly predisposed to greater risks of cardiovascular events compared to those with a persistent MHO phenotype. The aim of this study was to evaluate the predictive performance of wrist circumference for this transition in adults over a 15.5-year follow-up.

METHODS: We included 309 males and 821 females with the age of ≥18 years old, body mass index ≥25 kg/m

RESULTS: The overall rate of transition from MHO to MUO phenotype was 87.1% in males and 77.5% in females. The hazard ratios (HRs) with 95% CI across second and third tertiles of wrist circumference were 0.89 (0.64-1.24) and 1.31 (0.99-1.73) in men (P for trend =0.027); and 1.34 (1.09-1.66) and 1.61 (1.30-2.00) in women (P for trend <0.001), respectively. After multivariable adjustment, HRs across second and third tertiles of wrist circumference were 0.92 (0.64-1.32) and 1.18 (0.83-1.67) in males (p for trend =0.352), and 1.32 (1.05-1.65) and 1.34 (1.06-1.96) in females (p for trend =0.025), respectively.

CONCLUSIONS: Wrist circumference significantly predicts the transition from MHO to MUO phenotype in adults of both genders. However, it is an independent predictor of the transition only in females. Future studies are warranted to clarify the role of wrist circumference mechanisms on metabolic risk deterioration.

© 2021. The Author(s).

Keywords: Gender; Metabolically healthy obesity; Metabolically unhealthy obesity; Transition; Wrist circumference

References

  1. Collaboration NRF. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19 2 million participants. Lancet. 2016;387(10026):1377–96. - PubMed
  2. Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659–724. - PubMed
  3. Rey-Lopez J, De Rezende L, Pastor-Valero M, Tess B. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes Rev. 2014;15(10):781–90. - PubMed
  4. Lin H, Zhang L, Zheng R, Zheng Y. The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: a PRISMA-compliant article. Medicine. 2017;96(47). - PubMed
  5. Blüher M. Metabolically healthy obesity. Endocr Rev. 2020;41(3):bnaa004. - PubMed
  6. Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze MB. Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(9):956–66. - PubMed
  7. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758–69. - PubMed
  8. Kouvari M, Panagiotakos DB, Yannakoulia M, Georgousopoulou E, Critselis E, Chrysohoou C, et al. Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: the ATTICA cohort study. Metabolism. 2019;93:18–24. - PubMed
  9. Lin L, Zhang J, Jiang L, Du R, Hu C, Lu J, et al. Transition of metabolic phenotypes and risk of subclinical atherosclerosis according to BMI: a prospective study. Diabetologia. 2020;1-12. - PubMed
  10. Cho YK, Kang YM, Yoo JH, Lee J, Park J-Y, Lee WJ, et al. Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: a nationwide population-based cohort study. Metabolism. 2019;97:50–6. - PubMed
  11. Kelishadi R, Qorbani M, Hosseini M, Bahreynian M, Djalalinia S, Motlagh ME, et al. Percentiles for anthropometric measures in Iranian children and adolescents: the CASPIAN-IV study. J Pediatr Endocrinol Metab. 2016;29(9):1069–76. - PubMed
  12. Kajale N, Khadilkar A, Chiplonkar S, Khadilkar V. Body fat indices for identifying risk of hypertension in Indian children. Indian Pediatr. 2014;51(7):555–60. - PubMed
  13. Ho HCH, Maddaloni E, Buzzetti R. Risk factors and predictive biomarkers of early cardiovascular disease in obese youth. Diabetes Metab Res Rev. 2019;35(4):e3134. - PubMed
  14. Luordi C, Maddaloni E, Bizzarri C, Pedicelli S, Zampetti S, D’Onofrio L, et al. Wrist circumference is a biomarker of adipose tissue dysfunction and cardiovascular risk in children with obesity. J Endocrinol Investig. 2020;43(1):101–7. - PubMed
  15. Mehrkash M, Heshmat R, Qorbani M, Motlagh ME, Djalalinia S, Zamani S, et al. Association of neck, wrist and hip circumferences with kidney function in children and adolescents: The CASPIAN-V Study. J Pediatr Res. 2019;6(3):234–42. - PubMed
  16. Amisi CA, Ciccozzi M, Pozzilli P. Wrist circumference: a new marker for insulin resistance in African women with polycystic ovary syndrome. World J Diabetes. 2020;11(2):42. - PubMed
  17. Jahangiri Noudeh Y, Hadaegh F, Vatankhah N, Momenan AA, Saadat N, Khalili D, et al. Wrist circumference as a novel predictor of diabetes and prediabetes: results of cross-sectional and 8.8-year follow-up studies. J Clin Endocrinol Metab. 2013;98(2):777–84. - PubMed
  18. Maddaloni E, Cavallari I, De Pascalis M, Keenan H, Park K, Manfrini S, et al. Relation of body circumferences to cardiometabolic disease in overweight-obese subjects. Am J Cardiol. 2016;118(6):822–7. - PubMed
  19. Mohebi R, Mohebi A, Sheikholeslami F, Azizi F, Hadaegh F. Wrist circumference as a novel predictor of hypertension and cardiovascular disease: results of a decade follow up in a West Asian cohort. J Am Soc Hyperten. 2014;8(11):800–7. - PubMed
  20. Li Y, Liu Y, He J, Ma P, Yu L, Sun G. The association of wrist circumference with hypertension in northeastern Chinese residents in comparison with other anthropometric obesity indices. PeerJ. 2019;7:e7599. - PubMed
  21. Obirikorang C, Obirikorang Y, Acheampong E, Anto EO, Toboh E, Asamoah EA, et al. Association of wrist circumference and waist-to-height ratio with cardiometabolic risk factors among type II diabetics in a Ghanaian population. J Diabetes Res. 2018;2018. - PubMed
  22. Namazi N, Djalalinia S, Mahdavi-Gorabi A, Asayesh H, Mansourian M, Noroozi M, et al. Association of wrist circumference with cardio-metabolic risk factors: a systematic review and meta-analysis. Eat Weight Disord. 2020;25(1):151–61. - PubMed
  23. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10(1):5. - PubMed
  24. Ainsworth BE, Jacobs JD, Leon AS. Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc. 1993;25(1):92–8. - PubMed
  25. Committee IR. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-short and long forms. http://www.ipaq.ki.se/scoring.pdf . 2005. - PubMed
  26. Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640–5. - PubMed
  27. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009;32(6):1092–7. - PubMed
  28. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69(1):239–41. - PubMed
  29. Hwang Y, Hayashi T, Fujimoto W, Kahn S, Leonetti D, McNeely M, et al. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int J Obes. 2015;39(9):1365–70. - PubMed
  30. Kang YM, Jung CH, Cho YK, Jang JE, Hwang JY, Kim EH, et al. Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype. PLoS One. 2017;12(6):e0179635. - PubMed
  31. Eshtiaghi R, Keihani S, Hosseinpanah F, Barzin M, Azizi F. Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study. Int J Obes. 2015;39(3):514–9. - PubMed
  32. Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Cuervo M, Goni L, Martinez JA. Genetic and nongenetic factors explaining metabolically healthy and unhealthy phenotypes in participants with excessive adiposity: relevance for personalized nutrition. Ther Adv Endocrinol Metab. 2019;10:2042018819877303. - PubMed
  33. Kogelman LJ, Fu J, Franke L, Greve JW, Hofker M, Rensen SS, et al. Inter-tissue gene co-expression networks between metabolically healthy and unhealthy obese individuals. PLoS One. 2016;11(12):e0167519. - PubMed
  34. Povel C, Boer J, Reiling E, Feskens E. Genetic variants and the metabolic syndrome: a systematic review. Obes Rev. 2011;12(11):952–67. - PubMed
  35. Ahangar OG, Javanrouh N, Daneshpour MS, Barzin M, Valizadeh M, Azizi F, et al. Genetic markers and continuity of healthy metabolic status: Tehran cardio-metabolic genetic study (TCGS). Sci Rep. 2020;10(1):1–8. - PubMed
  36. Zheng R, Zhou D, Zhu Y. The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis. J Epidemiol Community Health. 2016;70(10):1024–31. - PubMed
  37. Roberson LL, Aneni EC, Maziak W, Agatston A, Feldman T, Rouseff M, et al. Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality--a systematic review. BMC Public Health. 2014;14(1):14. - PubMed
  38. Bell JA, Hamer M, Sabia S, Singh-Manoux A, Batty GD, Kivimaki M. The natural course of healthy obesity over 20 years. J Am Coll Cardiol. 2015;65(1):101–2. - PubMed
  39. Amini A, Soltanian N, Iraj B, Askari G, Ebneyamin S, Ghias M, et al. Association of wrist circumference with cardio metabolic risk factors. J Pak Med Assoc. 2012;62(3 Suppl 2):S34–6. - PubMed
  40. Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body mass index, waist circumference and waist: hip ratio as predictors of cardiovascular risk—a review of the literature. Eur J Clin Nutr. 2010;64(1):16–22. - PubMed
  41. Capizzi M, Leto G, Petrone A, Zampetti S, Papa RE, Osimani M, et al. Wrist circumference is a clinical marker of insulin resistance in overweight and obese children and adolescents. Circulation. 2011;123(16):1757–62. - PubMed
  42. Thomas D, Udagawa N, Hards D, Quinn J, Moseley J, Findlay D, et al. Insulin receptor expression in primary and cultured osteoclast-like cells. Bone. 1998;23(3):181–6. - PubMed
  43. Fukumoto S, Martin TJ. Bone as an endocrine organ. Trends Endocrinol Metab. 2009;20(5):230–6. - PubMed
  44. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130(3):456–69. - PubMed
  45. Khazem S, Itani L, Kreidieh D, El Masri D, Tannir H, Citarella R, et al. Reduced lean body mass and cardiometabolic diseases in adult males with overweight and obesity: a pilot study. Int J Environ Res Public Health. 2018;15(12):2754. - PubMed
  46. Khadra D, Itani L, Tannir H, Kreidieh D, El Masri D, El Ghoch M. Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: a systematic review and meta-analysis. World J Diabetes. 2019;10(5):311. - PubMed
  47. Ferrara L, Capaldo B, Mancusi C, Lee E, Howard BV, Devereux RB, et al. Cardiometabolic risk in overweight subjects with or without relative fat-free mass deficiency: the Strong Heart Study. Nutr Metab Cardiovasc Dis. 2014;24(3):271–6. - PubMed
  48. Derakhshan A, Eslami A, Bozorgmanesh M, Sheikholeslami F, Azizi F, Hadaegh F. Wrist circumference as a novel negative risk factor for cardiovascular disease among adult men: a median follow-up of 9 years. J Endocrinol Investig. 2016;39(7):763–8. - PubMed

Publication Types